|
1
|
Behin A, Hoang-Xuan K, Carpentier AF and
Delattre JY: Primary brain tumours in adults. Lancet. 361:323–331.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kawano H, Hirano H, Yonezawa H, Yunoue S,
Yatsushiro K, Ogita M, Hiraki Y, Uchida H, Habu M, Fujio S, et al:
Improvement in treatment results of glioblastoma over the last
three decades and beneficial factors. Br J Neurosurg. 29:206–212.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakagawa Y, Sasaki H, Ohara K, Ezaki T,
Toda M, Ohira T, Kawase T and Yoshida K: Clinical and molecular
prognostic factors for long-term survival of the patients with
glioblastomas in a single-institutional consecutive cohort. World
Neurosurg. 106:165–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozdemir Y, Akin ML, Sucullu I, Balta AZ
and Yucel E: Pretreatment neutrophil/lymphocyte ratio as a
prognostic aid in colorectal cancer. Asian Pac J Cancer Prev.
15:2647–2650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buttigliero C, Pisano C, Tucci M, Vignani
F, Bertaglia V, Iaconis D, Guglielmini P, Numico G, Scagliotti GV
and Di Maio M: Prognostic impact of pretreatment
neutrophil-to-lymphocyte ratio in castration-resistant prostate
cancer patients treated with first-line docetaxel. Acta Oncol.
56:555–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bar-Ad V, Palmer J, Li L, Lai Y, Lu B,
Myers RE, Ye Z, Axelrod R, Johnson JM, Werner-Wasik M, et al:
Neutrophil to lymphocyte ratio associated with prognosis of lung
cancer. Clin Transl Oncol. 19:711–717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang X, Du P and Yang Y: The clinical use
of neutrophil-to-lymphocyte ratio in bladder cancer patients: A
systematic review and meta-analysis. Int J Clin Oncol. 22:817–825.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang PF, Song HW, Cai HQ, Kong LW, Yao K,
Jiang T, Li SW and Yan CX: Preoperative inflammation markers and
IDH mutation status predict glioblastoma patient survival.
Oncotarget. 8:50117–50123. 2017.PubMed/NCBI
|
|
11
|
Dolan RD, McSorley ST, Horgan PG, Laird B
and McMillan DC: The role of the systemic inflammatory response in
predicting outcomes in patients with advanced inoperable cancer:
Systematic review and meta-analysis. Crit Rev Oncol Hematol.
116:134–146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faria SS, Fernandes PC Jr, Silva MJ, Lima
VC, Fontes W, Freitas-Junior R, Eterovic AK and Forget P: The
neutrophil-to-lymphocyte ratio: A narrative review.
Ecancermedicalscience. 10:7022016.PubMed/NCBI
|
|
13
|
Bambury RM, Teo MY, Power DG, Yusuf A,
Murray S, Battley JE, Drake C, O'Dea P, Bermingham N, Keohane C, et
al: The association of pre-treatment neutrophil to lymphocyte ratio
with overall survival in patients with glioblastoma multiforme. J
Neurooncol. 114:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han S, Liu Y, Li Q, Li Z, Hou H and Wu A:
Pre-treatment neutrophil-to-lymphocyte ratio is associated with
neutrophil and T-cell infiltration and predicts clinical outcome in
patients with glioblastoma. BMC Cancer. 15:6172015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mason M, Maurice C, McNamara MG, Tieu MT,
Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG,
et al: Neutrophil-lymphocyte ratio dynamics during concurrent
chemo-radiotherapy for glioblastoma is an independent predictor for
overall survival. J Neurooncol. 132:463–471. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lopes M, Carvalho B, Vaz R and Linhares P:
Influence of neutrophil-lymphocyte ratio in prognosis of
glioblastoma multiforme. J Neurooncol. 136:173–180. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McNamara MG, Lwin Z, Jiang H, Templeton
AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N and
Mason WP: Factors impacting survival following second surgery in
patients with glioblastoma in the temozolomide treatment era,
incorporating neutrophil/lymphocyte ratio and time to first
progression. J Neurooncol. 117:147–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
